Private Equity Firms in Hyderabad: Top Firms in 2026

Key Facts

• Hyderabad hosts 64 active private equity and venture capital funds as of January 2026, making it one of South India's most active PE markets.
• These funds have collectively deployed more than $120 billion across 4,888 investment rounds in over 730 portfolio companies.
• In the past five years, Hyderabad-based PE funds participated in 436 seed-stage rounds worth $682 million and 569 early-stage rounds worth $6.97 billion.
• Late-stage rounds over the same period totaled 472 transactions worth $33.2 billion, reflecting the depth of growth capital available at scale.
• The dominant strategy is growth equity with a significant minority stake, supplemented by impact investing, venture capital, and selective buyout transactions.
• Healthcare, life sciences, and pharma represent the single largest sector concentration, driven by Hyderabad's established pharmaceutical cluster.
• Check sizes range from $480,000 for early-stage rounds to $70 million for healthcare growth equity, giving founders a wide band of capital sources to target.

Hyderabad Private Equity Overview

Hyderabad has built a distinctive PE ecosystem by combining deep pharma and life sciences infrastructure with a fast-growing technology sector. Genome Valley, a dedicated life sciences and biotech zone, anchors one end of the investment landscape. HITEC City's Cyber Gateway corridor and the adjacent Madhapur district provide the primary commercial base for fund offices and PE-backed companies alike.

The city's investor base divides into three tiers. Hyderabad-headquartered specialist funds such as InvAscent and Caspian Impact Investments form the local anchor layer, with deep networks in pharma and impact sectors respectively. Mumbai-headquartered pan-India PE firms, including ICICI Venture, True North, and Gaja Capital, provide mid-market growth capital with documented Hyderabad portfolio exposure. Singapore-based healthcare specialist Quadria Capital rounds out the landscape, deploying $30 to $70 million per transaction in Indian hospitals and pharma companies.

Telangana's policy environment has reinforced this activity. SEBI's Alternative Investment Fund (AIF) regulatory framework governs domestic fund structuring. Category II AIF registration covers most growth equity and impact vehicles active in Hyderabad, and a specialist legal ecosystem supporting AIF setup and compliance has developed around the city's PE community.

Hyderabad PE Firms: Comparison

The table covers the most active private equity and venture capital investors with Hyderabad headquarters or documented investment activity in the city's primary sectors. Check size figures replace AUM where individual fund assets are undisclosed.

ICICI Venture leads on exit history with 55 completed transactions across five fund vintages. For pharma-specific capital, InvAscent and Quadria Capital hold the strongest sector mandates. The three Hyderabad-headquartered impact funds represent a local concentration of impact capital that few Indian cities outside Mumbai can match.

Top Picks by Investment Strategy

Largest Exit Track Record: ICICI Venture. With $2.05 billion deployed since inception, 63 investments, and 55 exits, it has the deepest transaction history of any India PE firm with documented Hyderabad exposure. Portfolio companies Bharat Biotech and KIMS hospitals represent its most prominent Hyderabad bets.

Healthcare and Pharma Specialist: InvAscent. The Hyderabad-headquartered fund is the strongest local option for pharma, MedTech, and animal health companies. It writes checks of $10 to $40 million per investment with a 42-company portfolio built over nearly two decades.

Largest Single-Check Healthcare Investor: Quadria Capital. At $30 to $70 million per deal, Quadria targets late-stage hospitals and pharma firms across Asia. For Hyderabad pharma companies at scale, it represents the highest-capacity healthcare mandate accessible from this market.

Mid-Market Growth Equity Leader: Gaja Capital. Investing from a $240 million fund across education, financial services, and consumer, its check range of $1.2 to $30 million serves the widest band of mid-market company needs.

Most Established Impact Investor: Caspian Impact Investments. Active since 2005 with 22 portfolio companies, Caspian is Hyderabad's longest-running impact fund. Financial inclusion and fintech founders seeking a capital partner with social return requirements will find its mandate the closest fit.

Climate and Gender Capital: Impact Investment Exchange. Its dual mandate on gender equality and climate resilience, with 20 portfolio companies since 2009, fills a specific ESG niche no other Hyderabad fund replicates directly.

ESG-Oriented Mid-Market Operator: True North. With 49 investments and a formal ESG reporting framework, including its published 2022 ESG Report, it is the strongest choice for management teams preparing for public market scrutiny on governance and climate metrics.

Top Private Equity Firms in Hyderabad in Detail

InvAscent

The dominant healthcare PE investor headquartered in Hyderabad, InvAscent has built a 42-company portfolio covering pharma, healthcare services, animal health, and MedTech. Its investment thesis targets Indian companies at the growth equity stage, writing $10 to $40 million per deal for a significant minority stake with board governance rights. General partners at InvAscent bring direct pharma operating experience. That sector depth gives the fund underwriting credibility on regulatory filings, product pipelines, and manufacturing scale-up that generalist buyout firms cannot replicate. Pharma contract manufacturers seeking expansion capital for capacity or regulatory upgrades represent the clearest mandate fit.

Caspian Impact Investments

Caspian's 2005 founding predates most Hyderabad PE activity, and its 22-company portfolio reflects two decades of consistent impact-first deal making. Based in Nanakaramguda, the fund backs companies generating both financial returns and social benefit, with particular concentration in financial inclusion, non-banking financial companies (NBFCs), and fintech. Its limited partner (LP) base explicitly rewards social outcomes alongside financial performance. The fund participates at both venture and growth equity stages. That breadth makes it relevant across a wider band of company maturity than most other Hyderabad-based peers.

ICICI Venture

India's most prolific mid-market PE manager by exit count, ICICI Venture has completed more than 55 exits since 2002. Exit routes span IPOs on Indian exchanges, strategic M&A, secondary sales to larger PE funds, and post-IPO market disposals. Its Hyderabad portfolio includes two landmark investments. In 2006, it backed Bharat Biotech International, a vaccine and biopharmaceuticals manufacturer headquartered in Hyderabad. It also invested in KIMS hospitals, which grew to nine hospitals and approximately 3,000 beds across Andhra Pradesh and Telangana. ICICI Venture additionally executed India's first leveraged buyout in 2003, acquiring Tata Infomedia from the Tata Group. That deal was exited through a strategic sale to Network 18 Group. Historical assets under management (AUM) total $2.05 billion across five India Advantage Fund vintages.

True North

True North's defining characteristic is governance discipline applied consistently across a multi-decade portfolio. The firm published its ESG Report 2022, documenting climate action, social impact, and governance milestones across portfolio companies. That makes it one of the few Indian mid-market PE managers with formal ESG accountability to LPs. Its 49 investments and 19 exits since 1999 cover financial services, consumer, healthcare, and IT. True North invests with a "majority mindset," taking active board representation regardless of actual equity percentage. Management teams in regulated sectors preparing for IPO will find True North's governance infrastructure directly relevant to their public market readiness.

Gaja Capital

Gaja Capital's $240 million fund is the most clearly bounded mid-market growth equity vehicle on this list. Its transparent check range of $1.2 to $30 million covers education, financial services, and consumer sectors across India. With 32 investments and 9 exits, the firm has built a concentrated track record in sectors driven by India's expanding middle class. The investment thesis favors asset-light models with strong unit economics. That profile aligns well with SaaS, edtech, and financial services businesses emerging from Hyderabad's HITEC City corridor. Founders preparing for a growth round of $5 to $25 million will find Gaja's mandate one of the closest structural fits among pan-India growth equity funds.

Quadria Capital

Asia's most focused healthcare PE investor active in India, Quadria Capital targets hospitals, pharma companies, medical device businesses, and health insurance providers across South and Southeast Asia. Its $30 to $70 million transaction range positions it well above local growth-stage checks. For Hyderabad pharma companies with international expansion ambitions, Quadria represents the largest-ticket healthcare mandate accessible from this market. The Singapore-based general partnership brings cross-border experience suited to companies planning regulatory filings or distribution partnerships in Southeast Asian markets. Its focus on late-stage and pre-IPO transactions means it is most relevant for companies preparing for public market entry rather than early growth rounds.

Impact Investment Exchange

Impact Investment Exchange occupies a specific capital niche: gender equity and climate resilience combined in a single investment mandate. Its 20 portfolio companies since 2009 reflect a consistent thesis built on mobilizing capital for enterprises creating measurable social and environmental change. The fund uses both direct equity and gender-lens assessment tools, making it structurally distinct from financial-return-only PE vehicles. Its LP base includes development finance institutions that require documented impact metrics alongside financial returns. Women-led businesses, clean energy companies, and climate adaptation ventures in South India will find Impact Investment Exchange the most aligned institutional capital source locally.

Mile Deep Capital

Hyderabad's newest PE-adjacent fund, Mile Deep Capital launched in 2023 and has made five early-stage investments in startups and growth-stage entrepreneurs. Its model combines strategic guidance with capital, positioning it closer to venture capital than traditional buyout PE. The small portfolio reflects its early vintage rather than a narrow mandate. Pre-revenue or early-revenue founders seeking their first institutional ticket from a locally embedded fund manager will find it the most accessible Hyderabad-headquartered option at the early stage.

Investment Trends Shaping Hyderabad PE

Healthcare Services Consolidation

Hyderabad's pharma cluster continues to generate the city's highest concentration of PE deal flow. Prior investments in Bharat Biotech and KIMS hospitals validated the healthcare PE thesis for subsequent fund managers. Pharma contract manufacturing, diagnostic chains, and MedTech device companies currently draw the most active investment theses from specialist funds.

Impact Capital Momentum

Caspian's 22-company portfolio and Impact Investment Exchange's 20 portfolio companies have together built a local impact capital infrastructure that few Indian cities outside Mumbai can match. SEBI's Category II AIF structure allows both funds to raise domestic institutional capital alongside international development finance. Financial inclusion, gender equality, and climate resilience are the three active mandates sustaining consistent deal flow.

Technology and SaaS Investment Growth

HITEC City's enterprise software ecosystem is generating increasing investment opportunities for growth equity investors. AI, machine learning, and technology-enabled services have become the fastest-growing subsectors by new deal count. Pan-India growth equity funds, including Gaja Capital and True North, are deploying capital into profitable, asset-light technology businesses emerging from this corridor.

Fintech and Financial Services Capital

India's financial inclusion policy environment has sustained a multi-year investment cycle in Hyderabad-based NBFCs, payment companies, and digital lending businesses. Caspian Impact Investments has backed 22 companies in this cluster over two decades. Newer fintech models in insurance-tech, embedded finance, and SME credit are attracting additional growth equity capital from pan-India PE investors.

Clean Energy Long-Hold PE

Solar energy PE follows a distinct model: hold periods of eight to ten years, stable Power Purchase Agreement-backed cash flows, and a focus on plant efficiency metrics. Telangana's renewable energy policy has reinforced capital flow into clean infrastructure in the state. This patient capital approach differs structurally from growth equity and suits investors with infrastructure-style return expectations.

How to Evaluate PE Investors in Hyderabad

Mandate alignment is the first filter. A pharma company seeking $15 million belongs in InvAscent's pipeline before a generalist mid-market fund. A hospital group seeking $50 million fits Quadria Capital's mandate, not Caspian's. Sending an off-mandate pitch wastes both parties' time and signals poor market research to the fund.

Fund stage matters equally. InvAscent and Quadria invest at growth equity and late-stage. Caspian and Mile Deep Capital participate in earlier transactions. Matching company maturity to fund stage eliminates most dead-end introductions before they start.

Track record review should go beyond raw investment counts to exit quality and route diversity. ICICI Venture's 55 exits span IPOs, strategic M&A, secondary sales, and post-IPO disposals. That exit diversity signals the ability to create liquidity across varying market conditions, which matters to LPs evaluating internal rate of return (IRR) across fund vintages.

Governance terms vary significantly between funds. True North and ICICI Venture apply a "majority mindset" with active board representation regardless of stake size. Impact funds embed social impact governance alongside financial oversight. Founders should assess governance intensity against their operating bandwidth before signing a term sheet.

For due diligence preparation, a confidential information memorandum (CIM) with historical and projected profit and loss, unit economics, customer concentration, and regulatory compliance status is the baseline expectation. Funds with operating boards, including ICICI Venture, weight management team depth as a primary criterion alongside financial metrics.

Which Firm Fits Your Needs?

Pharma and healthcare founders in Hyderabad with revenues above ₹50 crore and capital needs of $10 to $40 million should prioritize InvAscent as the first institutional conversation. Companies with hospital group ambitions or pan-Asian pharma plans can add Quadria Capital to the shortlist, noting its $30 million minimum sets a clear scale threshold.

Growth-stage technology companies in HITEC City with proven unit economics are best aligned with Gaja Capital's $240 million fund or True North's mid-market mandate. Both funds deploy across India, write checks relevant to growth rounds of $5 to $25 million, and bring active board-level oversight. Limited partners building India-focused alternatives allocations should note that ICICI Venture's five-fund track record and 55 completed exits offer the longest auditable return history among firms with active Hyderabad exposure.

Impact investors and development finance institutions seeking a Hyderabad-anchored deployment vehicle have two clear options: Caspian Impact Investments for financial inclusion and fintech mandates, and Impact Investment Exchange for gender equality and climate resilience mandates. Early-stage founders seeking their first institutional check from a locally embedded fund manager should engage Mile Deep Capital, the youngest Hyderabad-headquartered vehicle with an active early-stage investment program.

Methodology

This guide to private equity firms in Hyderabad covers funds with either Hyderabad headquarters or documented active investment in Hyderabad-based companies. Market statistics, including the 64-fund count and $120 billion deployment figure, draw on PE industry database records current as of January 2026. Stage-level data covering seed, early-stage, and late-stage round counts reflects the five-year period ending January 2026. Firm profiles use publicly available portfolio information, fund documentation, and investment mandates disclosed through firm websites and market databases. Selection criteria were sector relevance, data availability, and documented investment activity. No commercial relationships influenced rankings or editorial assessments.